<?xml version="1.0" encoding="UTF-8"?>
<p>The third and fourth reasons are intertwined. Major mental illnesses are chronic and lifelong and affect all aspects of life, including sexual functioning. Sexual dysfunction impacts on quality of life and medication adherence. It is common knowledge that many medications used in the treatment of mental illness have a direct association with sexual dysfunction, decreased libido, erectile dysfunction, anorgasmia and decreased ejaculatory volume (
 <xref rid="B17" ref-type="bibr">17</xref>), yet these side effects are often overlooked, disregarded or forgotten in the decision making around medication choice. At the same time, this gap in clinical recognition and knowledge is compounded by patients' reluctance to self-report sexual dysfunction symptoms despite sexual dysfunction having a considerable impact on quality of life and adherence to antipsychotic medications (
 <xref rid="B18" ref-type="bibr">18</xref>â€“
 <xref rid="B20" ref-type="bibr">20</xref>). Evans et al. (
 <xref rid="B4" ref-type="bibr">4</xref>) points out that the barriers of addressing sexual health needs from a patient's perspective include clinical setting, communication difficulties, the possible consequence of addressing this with clinicians and medication related side effects. This is more profound in forensic patients, who often reside involuntarily for prolonged periods in a confined and strictly regulated hospital environment, where the clinical setting does not support or promote sexual experiences (
 <xref rid="B21" ref-type="bibr">21</xref>).
</p>
